Literature DB >> 27647557

[Quality of diagnosis information given to terminal cancer patients].

Sergi Font-Ritort1, José Antonio Martos-Gutiérrez2, Mercedes Montoro-Lorite3, Lluís Mundet-Pons4.   

Abstract

AIM: To determine the information that terminal cancer patients have about their diagnosis, identifying key words used, and quantifying the conspiracy of silence.
METHOD: A cross-sectional, analytical study was conducted by reviewing the hospice support team data base which contains the medical history and a semi-structured interview with terminal cancer patients in the first visit to the hospice. Demographic and socioeconomic data was collected, as well as relevant clinical information (diagnosis, prevalent symptoms, number of symptoms, patient functionality, QoL, information given, and words used).
RESULTS: Out of total of sample of 723 records, 77.87% (95% CI: 74.70-80.74) of the patients were properly informed about their diagnosis. The most used words were cancer in 26% of the patients, tumour in 51.59%, and for the remaining 10.65%, the word inflammation was used. Statistically significant differences of information were found between sexes, age, types of cancer, and hospital ward.
CONCLUSIONS: Terminal cancer patients have knowledge on their diagnosis, suggesting that the conspiracy of silence is present to a lesser extent. This knowledge is transmitted using different words and with euphemisms.
Copyright © 2016 Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Cancer; Communication; Comunicación; Cuidados paliativos; Cáncer; Palliative care; Revelación de la verdad; Truth disclosure

Mesh:

Year:  2016        PMID: 27647557     DOI: 10.1016/j.enfcli.2016.07.006

Source DB:  PubMed          Journal:  Enferm Clin        ISSN: 1130-8621


  1 in total

1.  Avoidant Coping of the Decision-Making Process on the Location of Care in Old Age: A Possible Conspiracy of Silence?

Authors:  Gema Serrano-Gemes; Isabel Gil; Adriana Coelho; Rafael Serrano-Del-Rosal
Journal:  Int J Environ Res Public Health       Date:  2021-12-08       Impact factor: 3.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.